Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 93.130 | 93.130 | 0.000 |
Bonds | 1.760 | 1.760 | 0.000 |
Other | 5.780 | 5.780 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.280 | 21.195 |
Price to Book | 4.698 | 4.173 |
Price to Sales | 2.075 | 2.490 |
Price to Cash Flow | 18.495 | 17.334 |
Dividend Yield | 1.710 | 1.320 |
5 Years Earnings Growth | 10.993 | 13.721 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.400 | 94.960 |
Basic Materials | 0.250 | 1.647 |
Technology | 0.140 | 2.816 |
Consumer Cyclical | 0.130 | 9.334 |
Energy | 0.070 | 0.070 |
Number of long holdings: 167
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.72 | 748.01 | -0.25% | |
Fecrmbjsc4te0035zarusd20240918 | - | 8.12 | - | - | |
Nedgroup Investments Corporate Money Market Fund C | ZAE000167946 | 7.67 | 1.000 | 0% | |
Novo Nordisk ADR | US6701002056 | 4.55 | 105.06 | +2.37% | |
UnitedHealth | US91324P1021 | 4.43 | 590.87 | -1.11% | |
Novo Nordisk ADR | US6701002056 | 4.42 | 105.06 | +2.37% | |
J&J | US4781601046 | 3.48 | 155.17 | -0.21% | |
Merck | DE0006599905 | 3.26 | 141.45 | -0.21% | |
AbbVie | US00287Y1091 | 2.95 | 176.95 | +3.04% | |
Oxford Sciences Enterprises (Gbp) | - | 2.68 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Sygnia Skeleton Balanced 70 Fund A | 7.63B | 11.68 | 10.60 | 8.70 | ||
Sygnia CPI 4 Fund B | 3.01B | 12.11 | 10.70 | 8.81 | ||
Sygnia CPI + 4% Fund D | 3.01B | 11.65 | 10.10 | 8.00 | ||
Sygnia 4th Ind Rev Global Eq A | 2.59B | 15.05 | 0.50 | - | ||
Sygnia 4th Indust Rev Global Eq B | 2.59B | 14.46 | 0.77 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review